Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Current Assets (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Current Assets for 2 consecutive years, with $238.8 million as the latest value for Q3 2023.

  • On a quarterly basis, Current Assets fell 20.0% to $238.8 million in Q3 2023 year-over-year; TTM through Sep 2023 was $238.8 million, a 20.0% decrease, with the full-year FY2022 number at $275.4 million, changed N/A from a year prior.
  • Current Assets was $238.8 million for Q3 2023 at LENZ Therapeutics, down from $251.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $343.8 million in Q1 2022 to a low of $238.8 million in Q3 2023.